3 completed, 1 recruiting, 1 terminated. 3 Phase 1, 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 3 | Completed 1, Recruiting 1, Terminated 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow this drug Literature Review of BI 836858 trials Research Report on BI 836858
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial to Find and Investigate a Safe Dose of F16IL2 and BI 836858 in Patients With AML Relapse After Allogeneic Hematopoietic Stem Cell Transplantation F16IL2, BI 836858 - Acute Myeloid Leukemia (AML) Relapse | Phase 1 | Completed | Philogen S.p.A. | 15 | 2016-12-02 | 2022-04-20 |
| Study of Biomarker-Based Treatment of Acute Myeloid Leukemia Samalizumab (BAML-16-001-S1), BI 836858 (BAML-16-001-S2), Laboratory Biomarker Analysis - Previously Untreated Relapsed Refractory Acute Myeloid Leukemia | Phase 2 / Phase 3 | Recruiting | Beat AML, LLC | 3000 | 2016-11-01 | 2026-09-03 |
| A Trial to Find and Investigate a Safe Dose of BI 836858 in Combination With Decitabine for Patients With Acute Myeloid Leukemia (AML) Decitabine, BI 836858 - Leukemia, Myeloid, Acute | Phase 1 / Phase 2 | Completed | Boehringer Ingelheim | 49 | 2016-06-16 | 2024-03-19 |
| Phase I/II Trial to Investigate BI 836858 in Myelodysplastic Syndromes Best Supportive Care, BI 836858 - Myelodysplastic Syndromes | Phase 2 | Terminated | Boehringer Ingelheim | 27 | 2015-01-22 | 2020-12-21 |
| BI 836858 Dose Escalation in Patients With Refractory or Relapsed Acute Myeloid Leukemia and in Patients With AML in Complete Remission With High Risk to Relapse BI 836858 - Leukemia, Myeloid, Acute | Phase 1 | Completed | Boehringer Ingelheim | 30 | 2012-09-13 | 2025-01-27 |
Leukemia, Myeloid, Acute (3) · Myelodysplastic Syndromes (1) · Recurrence (1)
Boehringer Ingelheim (3) · Beat AML, LLC (1) · Philogen S.p.A. (1)
United States (4) · Germany (3) · Italy (1) · Spain (1)
Alice Mims, MD (1)
2015 (1), 2018 (1)